Product References
Downregulation of CBX7 induced by EZH2 upregulates FGFR3 expression to reduce sensitivity to cisplatin in bladder cancer.
British journal of cancer
Ren J,Yu H,Li W,Jin X,Yan B
Sun Jan 01 00:00:00 UTC 2023
Downregulation of CBX7 induced by EZH2 upregulates FGFR3 expression to reduce sensitivity to cisplatin in bladder cancer.
British journal of cancer
Ren J,Yu H,Li W,Jin X,Yan B
Sun Jan 01 00:00:00 UTC 2023
Downregulation of CBX7 induced by EZH2 upregulates FGFR3 expression to reduce sensitivity to cisplatin in bladder cancer.
British journal of cancer
Ren J,Yu H,Li W,Jin X,Yan B
Sun Jan 01 00:00:00 UTC 2023
CBX7 Rejuvenates Late Passage Dental Pulp Stem Cells by Maintaining Stemness and Pro-angiogenic Ability.
Tissue engineering and regenerative medicine
Wu Y,Li B,Yu D,Zhou Z,Shen M,Jiang F
Thu Jun 01 00:00:00 UTC 2023
Loss of CBX2 causes genomic instability and Wnt activation in high grade serous ovarian carcinoma cells.
Molecular carcinogenesis
Ma Y,Liu L,Wei Z,Zhu M,Huang L,Wang S,Yi X,Ying F,Zhao S,Cai J,Wang Z,Sun S
Sat Apr 01 00:00:00 UTC 2023
Comprehensive analysis reveals the value of the expression of chromobox family members for bladder urothelial carcinoma prognosis.
Oncology letters
Meng X,Cao R,Liu X,Fu B,Luo L,Jiang M,Wang K,Liu Y,Zhu Q,Yang C,Zhou L
Sat Apr 01 00:00:00 UTC 2023
Circ_0006790 carried by bone marrow mesenchymal stem cell-derived exosomes regulates S100A11 DNA methylation through binding to CBX7 in pancreatic ductal adenocarcinoma.
American journal of cancer research
Gao G,Wang L,Li C
Sat Jul 16 00:00:00 UTC 2022
The RNF26/CBX7 axis modulates the TNF pathway to promote cell proliferation and regulate sensitivity to TKIs in ccRCC.
International journal of biological sciences
Liu W,Wang H,Jian C,Li W,Ye K,Ren J,Zhu L,Wang Y,Jin X,Yi L
Fri Apr 15 00:00:00 UTC 2022
The RNF26/CBX7 axis modulates the TNF pathway to promote cell proliferation and regulate sensitivity to TKIs in ccRCC.
International journal of biological sciences
Liu W,Wang H,Jian C,Li W,Ye K,Ren J,Zhu L,Wang Y,Jin X,Yi L
Fri Apr 15 00:00:00 UTC 2022
CBX7 represses the POU2F2 to inhibit the PD-L1 expression and regulate the immune response in bladder cancer.
Biochemical and biophysical research communications
Ren W,Ren J,Zhang N,Liu X,Deng Y,Jiang Y,Yan B,Xiao X,Yu H
Tue Jul 12 00:00:00 UTC 2022
CBX7 represses the POU2F2 to inhibit the PD-L1 expression and regulate the immune response in bladder cancer.
Biochemical and biophysical research communications
Ren W,Ren J,Zhang N,Liu X,Deng Y,Jiang Y,Yan B,Xiao X,Yu H
Tue Jul 12 00:00:00 UTC 2022
CBX7 represses the POU2F2 to inhibit the PD-L1 expression and regulate the immune response in bladder cancer.
Biochemical and biophysical research communications
Ren W,Ren J,Zhang N,Liu X,Deng Y,Jiang Y,Yan B,Xiao X,Yu H
Tue Jul 12 00:00:00 UTC 2022
CBX7 represses the POU2F2 to inhibit the PD-L1 expression and regulate the immune response in bladder cancer.
Biochemical and biophysical research communications
Ren W,Ren J,Zhang N,Liu X,Deng Y,Jiang Y,Yan B,Xiao X,Yu H
Tue Jul 12 00:00:00 UTC 2022
Identification and Validation of Chromobox Family Members as Potential Prognostic Biomarkers and Therapeutic Targets for Human Esophageal Cancer.
Frontiers in genetics
Fang X,Wang J,Chen J,Zhuang M,Huang T,Chen Z,Huang Y,Zheng B,Wang X
Sat Jul 16 00:00:00 UTC 2022
Identification and Validation of Chromobox Family Members as Potential Prognostic Biomarkers and Therapeutic Targets for Human Esophageal Cancer.
Frontiers in genetics
Fang X,Wang J,Chen J,Zhuang M,Huang T,Chen Z,Huang Y,Zheng B,Wang X
Sat Jul 16 00:00:00 UTC 2022
CBX7, a Potential Prognostic Biomarker in Lung Adenocarcinoma.
OncoTargets and therapy
Yang Y,Hu Z,Sun H,Yu Q,Yang L,Yin F,Sun Y,Pu L,Zhu X,Li S,Chen X,Zhao Y
Fri Apr 29 00:00:00 UTC 2022